Study of Immunotherapy to Treat Advanced Prostate Cancer
Completed · Phase 3 · Has a placebo group
Conditions studied: Prostate Cancer
In brief
The purpose of the study is to determine if advanced prostate cancer patients that are treated with radiotherapy (RT) plus ipilimumab live longer that those treated with RT alone
Key facts
- Study ID
- NCT00861614
- Run by
- Bristol-Myers Squibb
- People needed
- 988
- Starts
- 2009-05-01
- Expected to finish
- 2015-08-01
- Last updated by the study team
- 2016-09-30
Who can join
Age: 18 and older. Sex: male. Healthy volunteers: not accepted.
You may qualify if…
- Advanced prostate cancer
- At least 1 bone metastasis
- Testosterone < 50 ng/dl
- Prior treatment with docetaxel
You may not qualify if…
- Brain metastasis
- Autoimmune disease
- Known HIV, Hep B, or Hep C infection
- More than 2 prior systemic anticancer regimens for prostate cancer
- Prior treatment on BMS CA180227 for prostate cancer
Where it is running
- Alaska Clinical Research Center, Llc — Anchorage, Alaska, United States
- Arizona Clinical Research Center, Inc. — Tucson, Arizona, United States
- Highlands Oncology Group, P.A. — Fayetteville, Arkansas, United States
- Marsha G. Fink, Md, Inc. — Fountain Valley, California, United States
- Loma Linda University Cancer Center — Loma Linda, California, United States
- Usc/Norris Comprehensive Cancer Center — Los Angeles, California, United States
- Prostate Oncology Specialists, Inc. — Marina del Rey, California, United States
- Comprehensive Cancer Center — Palm Springs, California, United States
- Va San Diego Healthcare System — San Diego, California, United States
- Pacific Hematology Oncology Associates — San Francisco, California, United States
- Baptist Cancer Institute — Jacksonville, Florida, United States
- Orlando Health, Inc — Orlando, Florida, United States
- Suburban Hematology-Oncology Associates, Pc — Lawrenceville, Georgia, United States
- University Of Chicago — Chicago, Illinois, United States
- Cancer Care Specialists Of Central Illinois — Decatur, Illinois, United States
- Edward Cancer Center — Naperville, Illinois, United States
- Mid-Illinois Hematology & Oncology Associates, Ltd — Normal, Illinois, United States
- University Of Iowa Hospitals And Clinics — Iowa City, Iowa, United States
- Siouxland Hematology-Oncology Assoc., Llp — Sioux City, Iowa, United States
- Hutchinson Clinic, Pa — Hutchinson, Kansas, United States
- Kentucky Cancer Clinic — Hazard, Kentucky, United States
- The Bunting-Blaustein Cancer Research Building — Baltimore, Maryland, United States
- Frederick Memorial Hospital Regional Cancer Therapy Center — Frederick, Maryland, United States
- Dana Farber Cancer Institute — Boston, Massachusetts, United States
- Southern Cancer Center — Mobile, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.